Epileptic Seizures

Stroke

Levetiracetam tablets 250-500 mg. The drug dosage will be up-titrated from 250 mg bid in the first 2 weeks to 500 mg bid during the rest of the treatment period. The dosage can be incremented until 1500 mg bid, at Investigator judgement if crisis continue, or it can be reduced in case of adverse events

Levetiracetam

Carbamazepina tablets 200 mg. The drug dosage will be up-titrated from 100 mg die in the first 3 days to 100 mg bid during days 4 to 7, to 200 mg bid in the 2nd week, to 300 mg bid during the rest of the treatment period. The dosage can be incremented until 800 mg bid, at Investigator judgement if crisis continue, or it can be reduced in case of adverse events

Carbamazepine

Ospedale S. Giacomo

Ospedale S. Croce E Carle

Ospedale S. Martino

Istituto Clinico Humanitas

USL 2 Ospedale B.G. Villa

Ospedale Civile San Giovanni Battista di Foligno

Ospedale Santa Maria della Misericordia

Istituto Neurologico C. Mondino

Ospedale Guzzardi

Ospedale Di Portogruaro

Ospedale Civile

Policlinico Umberto I

Ospedale A. Perrino

Ospedale Cannizzaro

Ospedale San Martino

Ospedale Civile Imperia ASL 1

Ospedale A. Cardarelli-

Ospedale Cardarelli

Ospedale Civico

Osp. Guglielmo da saliceto

Arcispedale S. Maria Nuova

Ospedale SS. Annunziata - Ospedale Civile

Ospedale Molinette-Università di Torino

Azienda Ospedaliera Universitaria Trieste

Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis

Multicenter, Comparative, Randomized, Open Trial to Evaluate Efficacy and Safety of Levetiracetam Versus Carbamazepine in Post Stroke Late Onset Crisis

Dr. Domenico Consoli

Scienze Neurologiche Ospedaliere

Levetiracetam dose schedule Days 1-4 250 mg bid Days 5- 19 500 mg bid Days 20 -70 1000 mg bid Days 71-78 500 mg bid Days 79-85 250 mg bid Days 86-91

Historical controls from COMBINE study who receive a placebo

Alcoholism

Historical controls

Boston University Dept of Psychiatry Clinical Studies Unit

The Effects of Levetiracetam on Alcohol Dependent Subjects

The primary outcome of this study will be determined by comparing the mean drinks consumed per day at baseline (the month prior to the screening session) compared with the mean drinks per day consumed during week 11 of the treatment period.

Mean heavy drinks per drinking day, OCDS scores, MOS-Sleep Scores, and POMS scores.

Mean OCDS scores, MOS-Sleep Scores, and POMS scores.

Boston University

UCB Pharma

Motor Neuron Disease

Amyotrophic Lateral Sclerosis

Primary Lateral Sclerosis

Progressive Muscular Atrophy

Duke University ALS Clinic - 932 Morreene Road

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

A Pilot Trial of Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

Duke University

beta carboline

seizures

beta carboline/seizures

Levetiracetam Versus Carbamazepine in Post-Stroke Late Onset Crisis

The Effects of Levetiracetam on Alcohol Dependent Subjects

Levetiracetam for Cramps, Spasticity and Neuroprotection in Motor Neuron Disease

An bunachar luibheanna míochaine is iomláine le tacaíocht ón eolaíocht